Literature DB >> 8299631

Evidence of oxidative stress in chronic heart failure in humans.

J McMurray1, M Chopra, I Abdullah, W E Smith, H J Dargie.   

Abstract

Chronic heart failure (CHF) due to coronary artery disease (CAD) has been shown to be associated with increased plasma thiobarbituric reactive substances (TBARS) and reduced plasma thiol (PSH) concentrations, suggesting oxidative stress (OS). The aims of the present studies were (a) to determine whether OS is due to CAD or CHF per se and (b) to determine if a wider range of more specific markers of OS are abnormal in CHF. In the first study, two groups of patients (n = 15 each) were compared. Group 1 (11 male, mean age 56 years) had CHF due to CAD and group 2 (12 male, mean age 53 years) had non-CAD CHF. Median plasma TBARS in controls was 7.6 nmol.ml-1, 10.0 nmol.ml-1 in group 1 and 9.3 nmol.ml-1 in group 2 (P < 0.01 both groups vs control). Median PSH was 505 384 and 364 nmol.ml-1 (P < 0.05 and P < 0.01 vs control) respectively. Fifty-three patients with CHF were recruited in the second study. Malondialdehyde and PSH were 10.3 and 409 nmol.ml-1 respectively, compared to control values of 7.9 and 560 nmol.ml-1 (both P < 0.001). The median values for the following additional measures of OS in controls and patients were: erythrocyte superoxide dismutase 131 vs 114 U.l-1 (P = 0.005); caeruloplasmin oxidase 97 vs 197 U.l-1 (P < 0.01); erythrocyte glutathione 1.56 nmol.ml-1 vs 1.77 nmol.ml-1 (P < 0.02); plasma conjugated dienes 0.28 vs 0.33 optical density units (P = ns).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8299631     DOI: 10.1093/eurheartj/14.11.1493

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  55 in total

Review 1.  Statin therapy in cardiovascular diseases other than atherosclerosis.

Authors:  Dominique Beaudry; Kenneth E Stone; Suzanne Wetherold; John Hemphill; Dat Do; John McClish; Robert Chilton
Journal:  Curr Atheroscler Rep       Date:  2007-01       Impact factor: 5.113

Review 2.  NADPH oxidase-derived reactive oxygen species in cardiac pathophysiology.

Authors:  Alison Cave; David Grieve; Sofian Johar; Min Zhang; Ajay M Shah
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-12-29       Impact factor: 6.237

3.  Enhanced expression of the ubiquitin-proteasome system in the myocardium from patients with dilated cardiomyopathy referred for left ventriculoplasty: an immunohistochemical study with special reference to oxidative stress.

Authors:  Koji Otsuka; Fumio Terasaki; Hiroaki Shimomura; Bin Tsukada; Taiko Horii; Tadashi Isomura; Hisayoshi Suma; Yuro Shibayama; Yasushi Kitaura
Journal:  Heart Vessels       Date:  2010-09-29       Impact factor: 2.037

Review 4.  Sphingomyelinases: their regulation and roles in cardiovascular pathophysiology.

Authors:  Catherine Pavoine; Françoise Pecker
Journal:  Cardiovasc Res       Date:  2009-01-28       Impact factor: 10.787

Review 5.  The cardiac hypoxic niche: emerging role of hypoxic microenvironment in cardiac progenitors.

Authors:  Wataru Kimura; Hesham A Sadek
Journal:  Cardiovasc Diagn Ther       Date:  2012-12

Review 6.  X-ROS signaling in the heart and skeletal muscle: stretch-dependent local ROS regulates [Ca²⁺]i.

Authors:  Benjamin L Prosser; Ramzi J Khairallah; Andrew P Ziman; Christopher W Ward; W J Lederer
Journal:  J Mol Cell Cardiol       Date:  2012-12-06       Impact factor: 5.000

Review 7.  Redox signaling in cardiovascular health and disease.

Authors:  Nageswara R Madamanchi; Marschall S Runge
Journal:  Free Radic Biol Med       Date:  2013-04-11       Impact factor: 7.376

8.  Parkinson-susceptibility gene DJ-1/PARK7 protects the murine heart from oxidative damage in vivo.

Authors:  Filio Billia; Ludger Hauck; Daniela Grothe; Filip Konecny; Vivek Rao; Raymond H Kim; Tak W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

9.  Is elevated serum ceruloplasmin level associated with increased risk of coronary artery disease?

Authors:  Ayşe Yeşim Göçmen; Emel Sahin; Ender Semiz; Saadet Gümuşlü
Journal:  Can J Cardiol       Date:  2008-03       Impact factor: 5.223

Review 10.  Biomarkers in heart failure: a clinical review.

Authors:  J Paul Rocchiccioli; John J V McMurray; Anna F Dominiczak
Journal:  Heart Fail Rev       Date:  2008-12-03       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.